Home | Free 14-Day Trial | Tutorial | Help

Cancer, Thyroid Gland

Related Terms

Anaplastic Carcinoma
Cancer of the Thyroid
Follicular Carcinoma
Malignant Lymphoma of the Thyroid
Medullary Carcinoma
Papillary Carcinoma
Thyroid Cancer

Differential Diagnoses

Benign thyroid nodules or cysts
Goiter
Hashimoto's thyroiditis

Specialists

Endocrinologist
General Surgeon
Oncologist
Otolaryngologist
Radiology Oncologist

Comorbid Conditions

Sign-in as a subscriber or take a free trial to see the renowned Reed Group physiological recovery durations in place of this advertising.

The age of the individual with thyroid cancer may affect disability. Generally, older individuals do not recover from this condition as easily as do younger individuals. The type of thyroid cancer, the stage of the disease, the presence of metastasis of the thyroid tumor, and the method of treatment may also influence the length of disability. If radiation or chemotherapy is used, a longer period of disability may be expected.

Duration Trends from Reference Data

DURATION TRENDS

ICD-9-CM: 193

Cases	Mean	Min	Max	No Lost Time	Over 6 Months
1246	45	1	189	< 0.1%	0.5%

Percentile:	5^th	25^th	Median	75^th	95^th
Days:	10	18	33	61	120

Differences may exist between the duration tables and the reference graphs. Duration tables provide expected recovery periods based on the type of work performed by the individual. The reference graphs reflect the actual experience of many individuals across the spectrum of physical conditions, in a variety of industries, and with varying levels of case management. Selected graphs combine multiple codes based on similar means and medians.

Medical Codes

	ICD-9-CM:
	193 -	Cancer, Thyroid Gland
	198.89 -	Secondary Malignant Neoplasm of Other Specified Sites; Other Specified Sites, Other

Prognosis

The predicted outcome depends on the type and stage of thyroid cancer. The age of the individual at diagnosis is an important factor in all types of thyroid cancers. Younger people have a better prognosis than do the elderly. Five-year survival rates for papillary carcinoma as estimated by the American Cancer Society are as follows: stages I and II: 100%; stage III: 96%; stage IV: 57%. For follicular cancer, the rates are stage I and II: 100%; stage III: 79%; stage IV: 47%. For medullary thyroid cancer, the rates are as follows: stage I: 100%; stage II: 97%; stage III: 79%; stage IV: 24%. All anaplastic thyroid cancer is considered stage IV and has a 5-year survival rate of only 9% ("Detailed Guide").

Source: Medical Disability Advisor

Feedback
Send us comments, suggestions, corrections, or anything you would like us to hear. If you are not logged in, you must include your email address, in order for us to respond. We cannot, unfortunately, respond to every comment. If you are seeking medical advice, please contact your physician. Thank you!
Send this comment to: Sales Customer Support Content Development




This publication is designed to provide accurate and authoritative information in regard to the subject matter covered. It is published with the understanding that the author, editors, and publisher are not engaged in rendering medical, legal, accounting or other professional service. If medical, legal, or other expert assistance is required, the service of a competent professional should be sought. We are unable to respond to requests for advice. Any Sales inquiries should include an email address or other means of communication.